By combining diverse datasets and powerful analytical and modeling tools, drug developers are finding more potential ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and ...

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...

These efforts demonstrated how AI could respond to urgent health crises. Another recent success is the development of potential drugs for rare diseases. Traditional drug discovery often overlooks ...

Doctors have an overwhelming amount of individual patient data and medical research at their disposal to make diagnoses and ...

In a strategic move to expand its footprint in the healthcare sector, Advanced Micro Devices (AMD) has announced a $20 ...

El Lilly’s blockbuster weight-loss drug Zepbound is now eligible for coverage under Medicare prescription drug plans, when ...

AI art is seemingly everywhere online. These images are made by AI generators, programs that use generative AI to take your simple text description and transform it into a batch of images that ...

AI's extensive scope of work in various sectors, from healthcare to finance, is transforming industries and creating new ...

Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Invetx , a pioneer in protein-based therapeutics for animal health, today announced a strategic partnership to ...